Repligen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.About RGEN
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.
RGEN Key Statistics
Stock Snapshot
As of today, Repligen(RGEN) shares are valued at $166.82. The company's market cap stands at 9.39B, with a P/E ratio of 6491.05.
As of 2026-01-11, Repligen(RGEN) stock has fluctuated between $164.52 and $169.56. The current price stands at $166.82, placing the stock +1.4% above today's low and -1.6% off the high.
The Repligen(RGEN)'s current trading volume is 388.93K, compared to an average daily volume of 526.42K.
In the last year, Repligen(RGEN) shares hit a 52-week high of $182.52 and a 52-week low of $102.97.
In the last year, Repligen(RGEN) shares hit a 52-week high of $182.52 and a 52-week low of $102.97.
RGEN News
(RTTNews) - Repligen Corp. (RGEN), a life sciences company, on Tuesday announced that its board has elected Martin Madaus as chair of the board, effective March...
Claim 70% Off TipRanks Premium Repligen ( (RGEN) ) has provided an update. On January 6, 2026, Repligen Corporation announced that its board has elected indep...
Repligen (RGEN) Corporation announced that the Board has elected Dr. Martin Madaus as Chair of the Board, effective March 13. As previously communicated, Tony H...